Table 5. Highlighted mTOR Inhibition Antiaging Clinical Trials.
indication | intervention | status | sponsor | NCT no. |
---|---|---|---|---|
Geographic atrophy | Rapamycin | Complete | National Eye Institute, USA | NCT01445548 |
Aging frailty | Rapamycin | Complete | Mayo Clinic, USA | NCT01649960 |
Aging/epigenetics/inflammatory mediators | Rapamycin | Active, not recruiting | The University of Texas Health Science Center, USA | NCT04608448 |
Age-related sarcopenia | Rapamycin|resistance exercise | Recruiting | University of Nottingham, U.K. | NCT05414292 |